yet2.com - technology discovered here
Search Technologies Technology Needs
Browse Technologies
Browse Technology Needs

yet2.com corporate web site
 Tech of the Week
Each week we feature special technologies. Take a moment to view the other Tech of the Week articles, you may find one that meets a present need.
Conventional i-Line 365nm UV makes this flexible hydrophobic coating wettable in patterns for use in electronics and biochip applications
Cost-effective production techniques for improved sensitivity and portability of diffraction-based point-of-care biosensors
DuPont offers unique high-temperature, high-pressure fluoroelastomer for development  combines properties of ChemoursTM Teflon® and DuPontTM Kalrez®
Economical, fully synthetic, HEPA-level filter eliminates problem of boron contamination from glass fibers
High-efficiency cabin air filters, engine air filters, and oil filters using nanofiber technology
Hydrophobic nonwoven teamed with a nanolayer can filter HVAC, turbine intakes even in high-humidity/water-laden air
Pleated nanoweb filters offer long life, high capacity without relying on electrostatic charge
 Info
Tech of the Week is special. Click View Listing Details to see the full information on this technology -- even if you're not already a member.
To take full advantage of yet2.com, Become a Member.
 Archive List
Oracle database performance analysis software replaces manual methods and streamlines execution
Enhanced thermal conductivity and control over thermal isotropy for circuit boards, films, and other polymeric materials used in electronic components
Simplified route to large volumes of linear alkyl benzenes as precursors to surfactants
Nanometer-scale filter with pore sizes of 10-50nm for syringe, gas, virus filtration
High-speed spin-printing alternative to conductive ink-jet or photoresist printing uses functional particles in UHMW matrix
More articles...
 
 Tech of the Week

Biodegradable silica gel fiber technology for wound care, hard and soft tissue regeneration, and drug delivery

Bayer Innovation

SGF is the first inorganic, biodegradable fiber with wound-healing properties. It is suitable as a platform technology for hard and soft tissue regeneration (cartilage/bone), as well as for drug delivery and tissue engineering. SGF development has demonstrated during pre-clinical phase (in-vitro and in vivo) as well as in clinical trial promising potential to improve healing with excellent tolerability, safety, and no toxicity profile. The first product is approved in Europe as CE (IIb) and can be launched immediately. A 510(k) registration is possible in the US. The technology offers a unique, bio-resorbable scaffold for several applications in regenerative medicine, with an initial focus on chronic wound management. SGF acts as a physical scaffold to aid the growth of new cells and the collagen structure that supports them. As a scaffold, it can be used to deliver drugs over a wide area to aid in healing. The material itself is inorganic, but is integrated into the tissues and resorbed by the body. Unlike collagen, the SGF scaffold stayes in the wound for 1–2 weeks before resorption SGF is progressively resorbed and replaced by new tissue during the healing process. Dimension (thickness and size) as well as degradation speed can be adjusted from some millimeters up to several hundred square centimeters, from some days up to years. A GMP (ISO 14385)-certified production plant is also available for production.

Biodegradable silica gel fiber technology from Bayer.

SGF provides a matrix for tissue regeneration, first final application designed for chronic wound care.

Enhances: granulation and epitheliazation of the wound; cell proliferation of keratinocytes and fibroblasts; angiogenesis; collagen structure; prophylaxis of scar and keloid formation.

SGF promotes active growth of different cell types — fibroblasts, keratinocytes, osteoblasts, chondrocytes.

Degradation speed can be adjusted in the manufacture, from some days up to months.

SGF significantly enhances endothelial VEGF synthesis and promotes vessel growth.

SGF inhibits TFG and collagen synthesis of cytokine-activated fibroblasts and differentiation to myofibroblasts.

SGF clinical post-CE mark approval trial demonstrated effective wound healing and safety in conjunction with standard of care. Good tolerability was reported during a European clinical trial of 130 patients. SGF passed all ISO 10993 and FDA standard safety tests successfully and showed no safety concerns.

SGF offers significant potential for line extensions in regenerative medicine and drug delivery:

  • As a drug delivery system, SGF can act as a release system for pharmaceuticals and molecules, provide growth factors, and delivery e.g. for antiseptics and anesthetics.
  • For tissue regeneration (with and without cells), SGF works with hard and soft tissues, promotes bone regeneration with the SGF matrix and cartilage regeneration on the SGF matrix, and offers a tissue scaffold for skin regeneration.

SGF preclinical studies have proven the novel, unique mechanism of action for regenerative medicine and beyond.

SGF does not contain viable or non-viable animal or human tissue or extraneous proteins.

Unlike collagen, the scaffold stays in the wound for 1–2 weeks before resorption. SGF is progressively resorbed and replaced by new tissue during the healing process.

SGF promotes skin tissue growth and enhanced wound healing by providing a new three-dimensional structure for new cell growth.

Download this Tech of the Week as a PDF

You can download this Tech of the Week as a PDF file that you can share with co-workers. When viewed on a computer with an Internet connection, the PDF includes live links back to yet2.com and the technology listing.

Network and bookmark yet2.com

Twitter Bookmark and Share


Want to see more? Tech of the Week is special. Click View Listing Details to see the full information on this technology -- even if you're not already a member.
Want to know more? yet2.com will confidentially pass your question along to the provider of this technology and get back to you with an answer if it is available. This service is free. Ask the owner a question
Like an introduction? Deal directly with the licensing contact for this technology. You´ll need to provide some minimal information. This service is confidential and free of charge unless noted. Request an introduction
Send an email to a friend or colleague that contains a link to this technology. Email this listing to a friend
Boston, MA, USA       Liverpool, United Kingdom       Tokyo, Japan                  
Find a Technology |  List a Technology |  Insight |  Using this Site |  About Us |  Home |  Customer Support |  Help
Privacy Statement   |   Terms of Use Agreement   |   Technology Abstracts
Copyright © 1999-2016 by yet2.com, Inc. All Rights Reserved.
120.05.28.04